Companies: 10,795·Total market cap: $144.5T
U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc.

USRMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$64151
P/E Ratio—
52W High$0.0002
52W Low$0.0001
Overview
股票排行：Biotechnology·Healthcare·查看全部市值排行 →

U.S. Stem Cell, Inc.（USRM）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · USRM · 截至 Jun 9, 2026

关键指标

EPS (TTM)—usrm eps ttm · usrm earnings per shareEarnings history
PE Ratio (TTM)—usrm pe ratio ttm · usrm price to earningsPE Ratio deep dive
Revenue (TTM)—usrm revenue ttm · usrm annual revenueFull revenue history
Dividend Yield不分红does usrm pay dividends · usrm dividend yieldDividend history
Shares Outstanding—usrm shares outstanding · usrm floatShares outstanding history
Next EarningsTBAusrm earnings date · usrm next earningsEarnings history

探索 U.S. Stem Cell, Inc. 数据

usrm stock data · financials
市值$64,151usrm market cap · usrm valuation
分析师预测—
股息不分红does u.s. stem cell, inc. pay dividends · usrm dividend yield
营收—u.s. stem cell, inc. annual revenue · usrm revenue
盈利—usrm earnings · usrm eps
市盈率—usrm pe ratio · usrm price to earnings

关于 U.S. Stem Cell, Inc.

CEOMichael Tomas
IPO DateFeb 19, 2008
Employees11
CountryUS
Websiteus-stemcell.com

U.S. Stem Cell, Inc. is a biotechnology firm dedicated to the advancement and commercialization of autologous cellular therapies throughout the United States. Its core mission is to address a range of…

BiotechnologyHealthcareOTCUS

what is u.s. stem cell, inc. · usrm stock overview · u.s. stem cell, inc. company profile · who is u.s. stem cell, inc. ceo · usrm OTC · u.s. stem cell, inc. headquarters · u.s. stem cell, inc. business segments

关于股票概览与关键数据

U.S. Stem Cell, Inc.（USRM）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 19, 2008 在 OTC 上市。截至最近交易日，USRM 股价为 $0.00，市值约为 $64,151。过去12个月累计回报 —，年初至今回报 —。

常见问题

截至最近一个交易日，U.S. Stem Cell, Inc.（USRM）股价为 $0.00，在 OTC 上市，52周区间为 $0.00 – $0.00。

USRM 最新股价USRM quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议